ACTH 1–17 effects in multiple sclerosis

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Angeli A., Paccotti P., Orlandi F., Gaidano G., Ceresa F.: Differential patterns of plasma cortisol and aldosterone foliowing stimulation with increasing doses of the synthetic analogue (β-Ala¹, Lys¹⁷ 1–17-4-amino-N-butylamide. Hormone metab. Res.13, 24–27, 1981.
Article CAS Google Scholar
Ferrari E., Bossolo P. A., Carnevale Schianca G. P., Solerte S. B., Fioravanti M., Nascimbene M.: Adrenocortical responsiveness to the synthetic ACTH 1–17 analogue given at different circadian stages. Chronobiologia9, 133–141, 1982.
PubMed CAS Google Scholar
Geiger R.: Synthese eines Heptadecapeptides mit hoher adrenocorticotroper Wiskung. Justus Liebigs Ann. Chem.750, 165–170, 1971.
Article CAS Google Scholar
Vierhapper H., Waldhäusl W.: Comparison of the corticotropic action of two synthetic, substituted analogues of ACTH 1–17 and ACTH 1–18. J. clin. Endocrinol.47, 208–211, 1978.
CAS Google Scholar

Divisione Recupero Neurologico Sclerosi Multipla USSL 6, Ospedale S. Antonio Abate, Via Pastori 4, 21013, Gallarate, Italy
Stellio Marforio

Authors

Stellio Marforio
View author publications
You can also search for this author in PubMed Google Scholar

Marforio, S. ACTH 1–17 effects in multiple sclerosis. La Ricerca Clin. Lab. 14, 253–255 (1984). https://doi.org/10.1007/BF02904980

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.